News Headlines Article

A (Lower Cost) Healthcare Industry to Deal With a (Higher Cost) Healthcare Industry
The Health Care Blog

I was recently on the phone with a medical device company executive who was describing his company’s efforts to develop a non-invasive diagnostic device that could quantify the degree of cirrhosis in a patient with liver illness. It’s technology that his firm sees as timely given the recent introduction of Solavdi and other Hepatitis C therapies: the device will be offered as a way for healthcare systems (and insurers) to risk-stratify a bolus of patients who are waiting for hepatitis C antiviral therapy.

Commands